Lidocaine for Pessary Check Pain Reduction
Public ClinicalTrials.gov record NCT05493735. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Lidocaine for Pessary Removal and Reinsertion Pain Reduction
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to estimate the effect of lidocaine jelly on patient pain at the time of office pessary removal.
Study identification
- NCT ID
- NCT05493735
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 66 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 7, 2022
- Primary completion
- Jun 22, 2023
- Completion
- Jun 29, 2023
- Last update posted
- Dec 13, 2023
2022 – 2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| USF Health Outpatient Urogynecology Clinics | Tampa | Florida | 33606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Pelvic Organ Prolapse trials
Other public records listing Pelvic Organ Prolapse. Sorted by last update posted; newest first. Not a recommendation.
- NCT07692789: Improving Uroflowmetry Interpretability: Evaluating the Impact of Patient Reminder Systems Recruiting
- NCT05812859: Vaginal Orthosis Use After Vaginal Reconstructive Surgery Active, not recruiting
- NCT05731284: Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery Active, not recruiting
- NCT04829175: Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry Recruiting
- NCT04829058: GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study Recruiting
- NCT07218016: Accelerometer Measured Early Recovery After Prolapse Surgery Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05493735, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 13, 2023 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05493735 live on ClinicalTrials.gov.